Browse every story filed under this topic, curated from trusted publishers around the world.
GoodRx Partners with Novo Nordisk to Offer Self-Pay Pricing for New Oral Ozempic® Pill
What You Should Know GoodRx has launched access to self-pay pricing for Novo Nordisk’s Ozempic® pill (oral semaglutide) for patients with type 2 diabetes. Eligible patients can obtain the medication for as low as $149 per …
Read full story →
Axsome Drug’s FDA Approval Unlocks New Opportunity in Alzheimer’s Agitation
Axsome Therapeutics’ Auvelity expanded its label to include treating agitation in Alzheimer’s disease patients. It’s just the second FDA-approved drug …
'A horrible feeling' - Lowery desperate to avoid another relegation
Tom Lowery has already swallowed the bitter pill of relegation once in his career and doesn't want to taste it …
Novo Nordisk’s Rybelsus officially retired in US as ‘Ozempic pill’ takes branding center stage
The semaglutide franchise is changing up its branding as Novo Nordisk, seeing the cultural phenomenon that has become Ozempic, is …
Lilly touts 'encouraging' early days for Foundayo obesity launch, even as GLP-1 pill appears to lag Novo's
As Eli Lilly gets off to the races with the launch of its flagship oral GLP-1 Foundayo, the Indianapolis drugmaker—and …
Chiesi widens rare disease portfolio with $1.9bn KalVista buyout
Chiesi will assume ownership of Ekterly, an on-demand pill approved for hereditary angioedema.
STAT+: Boehringer’s obesity drug shows 16.6% weight loss; more data needed
Eli Lilly's deal with Profluent, Erasca's RAS-targeting cancer pill, and more biotech news today
‘Rogaine’ in a Pill? Oral Minoxidil Aces Major Hair Loss Trial
Veradermics' VDPHL01, an oral version of the existing drug minoxidil, showed strong results in a late stage clinical trial.
STAT+: Erasca touts strong, though preliminary, results in trial of pancreatic and lung cancer therapy
The drugmaker Erasca said results on its experimental pill in a trial of pancreatic cancer and non-small cell lung cancer …
STAT+: Astellas retries XLMTM gene therapy after deaths
Veradermics' hair loss pill late-stage trial success, FDA fast-tracks reviews for psychedelics, and more biotech news
Realme C100x Tipped to Launch in India Soon as Key Specifications and Design Surface Online
Realme C100x will be launched in India soon, a tipster claims. The leaker has also shared an image of the …
Pancreatic cancer pill, vaccine show promise: What to know
Two potential pancreatic cancer treatments are gaining recognition within the oncology community, according to reports from The New York Times …
Ozempic pill for children to launch in US market ‘soon’: Novo Nordisk
Novo Nordisk said April 23 it plans to seek expanded FDA approval for its Ozempic pill in the second half …
With trial win, Novo Nordisk eyes adolescent diabetes approval for oral semaglutide
With the recent launch of Novo Nordisk’s Wegovy pill opening the oral GLP-1 market for obesity, the company has now …
:max_bytes(150000):strip_icc():format(jpeg)/fw-these-kitchenaid-3-dish-towels-tout-179131ad5060476a8dc01820c3b86874.jpg)
These KitchenAid $3 Dish Towels Are Quick-Drying and Make Shoppers 'Look Forward' to Drying Dishes
These KitchenAid Dish towels don’t pill, shed, or fall apart after a single wash.
This Common Pill in Your Medicine Cabinet Could Help Stop Cancer From Spreading
Evolving studies suggest low‑dose aspirin may cut the risk of certain cancers and slow metastasis.
Amazon One Medical Launches Nationwide GLP-1 Management Program Integrated with Primary Care
What You Should Know The Launch: Amazon One Medical has rolled out a nationwide GLP-1 management program that explicitly integrates …
Merck amps up presence in HIV treatment market with FDA nod for novel combo pill Idvynso
The once-daily HIV treatment regimen offers a new mechanism of action in the HIV treatment market.
The Oral GLP-1 Tracker: Following the launch trajectories of Lilly’s Foundayo, Novo’s Wegovy pill
Fierce Pharma is launching the weekly Oral GLP-1 Tracker, leveraging analysts’ notes and IQVIA data to monitor prescription trends and …
STAT+: BioAge says experimental pill aimed at reducing heart risks significantly reduced inflammation
BioAge Labs said its investigational pill for cardiovascular risk prevention significantly reduced inflammation in an early study.
You've seen all articles for #pill.
Check back
soon
for new stories.